Ignite Creation Date:
2024-05-06 @ 1:25 PM
Last Modification Date:
2024-10-26 @ 1:13 PM
Study NCT ID:
NCT04018027
Status:
COMPLETED
Last Update Posted:
2022-04-04
First Post:
2019-07-09
Brief Title:
Study to Evaluate the Efficacy and Safety of Oral Difelikefalin CR845 for Moderate to Severe Pruritus in Subjects With Atopic Dermatitis
Sponsor:
Cara Therapeutics Inc
Organization:
Cara Therapeutics Inc
Organization Data
Organization:
Cara Therapeutics Inc
Class:
INDUSTRY
Study ID:
CR845-210501
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Cara Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None